查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1992077

胃镜市场：全球市场按产品、分销管道、最终用户和应用分類的预测，2026-2032年

Gastroscopes Market by Product, Distribution Channel, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年胃镜市值为 31.7 亿美元，预计到 2026 年将成长至 33.8 亿美元，复合年增长率为 7.33%，到 2032 年将达到 52.1 亿美元。

主要市场统计数据
基准年 2025 31.7亿美元
预计年份：2026年 33.8亿美元
预测年份 2032 52.1亿美元
复合年增长率 (%) 7.33%

对胃肠内视镜设备当前发展趋势的权威而简明的概述，旨在为临床和商业相关人员的策略决策提供支援。

胃镜检查仍然是消化器官系统诊断和治疗的基石，其配套设备也在快速发展。门诊手术中心、诊所和医院等终端使用者不断要求更高解析度的影像、更符合人体工学的操作体验以及能够缩短检查时间和降低感染风险的工作流程。同时，製造商也面临越来越高的期望，即整合数位化功能和售后服务能够延长其设备使用寿命。

技术进步、采购重点的转变、对感染预防的监管重点以及影响胃镜检查引入的数位化整合，这些因素显然是相互关联的。

胃镜市场环境正处于技术和营运变革的十字路口，这些变革正在重塑临床路径和经营模式。高清数位影像技术和影像软式内视镜的普及提高了人们对诊断的期望，而一次性耗材和消毒技术的进步正在重塑感染控制通讯协定。同时，用于病变检测和影像校正的人工智慧工具正从试验研究走向常规临床应用，这既提高了手术效率，也改变了临床医生的训练要求。

对 2025 年关税调整将如何影响胃肠内视镜供应链中的采购经济性、供应商策略和区域製造决策进行详细分析。

近期关税调整迫使全球先进医疗设备及相关耗材供应链进行重大重组。进口关税增加了依赖跨境零件流通的製造商和经销商的收货成本，迫使许多机构重新评估其采购地点并实现供应商多元化。因此，医院和门诊的采购团队越来越重视供应商的韧性、双重采购以及本地库存缓衝，以降低交货风险并保障医疗服务的连续性。

细分市场主导的洞察能够清楚地展现产品、最终用户、应用和分销趋势，从而製定有针对性的商业性和临床策略。

細項分析揭示了不同产品类型、终端用户群体、临床应用和分销管道的价值驱动因素各不相同。在产品细分中，软式和硬式胃镜满足不同的临床需求。软式设备为诊断和治疗流程提供了必要的便利性和操作性，而硬式器械则用于特定的手术场景，并具有不同的灭菌和再处理流程。软式内视镜本身又可分为光纤技术和视讯技术，其中视讯系统具有更佳的影像品质、数位整合以及更易于整合影像分析工具等优势。另一方面，硬式内视镜既可作为可重复使用的平台，优化了耐用性和单次使用成本，也可作为一次性产品，降低交叉感染风险并简化物流。

基于证据的区域比较主要全球市场的临床引入驱动因素、报销模式和生产趋势。

临床实务、报销框架和製造生态系统的区域差异显着影响部署模式和策略重点。在美洲，成熟的临床基础设施和集中采购网络为高品质影像平台和整合服务合约创造了机会，同时也推动了对本地製造和组装的投资，以降低关税风险并缩短产品上市时间。因此，该地区的相关人员对话通常围绕着总体拥有成本、与医院系统的互通性以及支援部署所需的循证依据。

对竞争策略的深入分析，展示了产品创新、服务和通路策略如何重新定义胃镜市场中的供应商定位。

胃镜生态系统中的主要企业正透过影像技术、一次性产品策略和服务交付的创新来脱颖而出。许多老牌製造商优先发展高解析度视讯系统和模组化架构，以便在不更换整个平台的情况下进行临床升级。同时，许多新兴企业则专注于一次性胃镜和混合服务模式，以解决感染控制问题，并减轻消毒能力有限的医疗机构的再处理负担。

为製造商、医疗保健提供者和通路合作伙伴提供切实可行的策略建议，将结构性变革转化为可持续的竞争优势。

产业领导企业可以透过调整产品蓝图，使其与临床工作流程和采购实际情况相契合，从而将市场复杂性转化为竞争优势。製造商应互通性，以便在分阶段升级产品时融入先进的影像处理和人工智慧功能，同时保障客户的投资。此外，投资可靠的临床证据并追踪真实世界的结果，可以实际展现诊断准确性和手术效率的提升，从而加速产品的普及应用。

为了支持研究结果，我们采用了严格的混合方法研究框架，结合了对主要相关人员的访谈、对监管和临床证据的审查以及供应链分析。

本研究采用混合方法，结合与关键相关人员的对话和对二手证据的三角检验，以确保得出可靠且可重复的结论。对临床负责人、采购专家、设备工程师和分销主管的结构化访谈是主要资讯来源，并辅以咨询委员会，该委员会负责检验新的主题和营运重点。这些努力提供了关于影响临床工作流程、决策标准和采购週期的实际限制的真实背景。

对策略挑战和麵向未来的优先事项进行简洁整合，明确界定了通往更安全、更有效率的胃镜解决方案的路径。

总而言之，胃镜市场在临床方面较为保守，但在商业性和技术方面却瞬息万变。对诊断清晰度、感染控制以及不断变化的采购优先事项的需求，正在重塑产品设计、分销和服务模式。目前的策略性应对措施主要围绕着整合先进的影像处理和数据功能、提供灵活的商业条款以及增强供应链抵御关税和贸易不确定性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：胃镜市场：依产品划分

  • 灵活的
    • 光纤
    • 影片
  • 硬度
    • 可重复使用的
    • 一次性的

第九章：胃镜市场：依通路划分

  • 离线
  • 在线的

第十章：胃镜市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十一章：胃镜市场：依应用领域划分

  • 复杂类型
  • 用于诊断
  • 治疗

第十二章：胃镜市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：胃镜市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：胃镜市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国胃镜市场

第十六章：中国胃镜市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ambu A/S
  • Ankon Medical Technologies Co., Ltd.
  • Aohua Endoscopy Co., Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • Ethicon
  • Fujifilm Holdings Corporation
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Olympus Corporation
  • PENTAX Medical
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • SonoScape Medical Corp.
  • Stryker Corporation
Product Code: MRR-20543276F0ED

The Gastroscopes Market was valued at USD 3.17 billion in 2025 and is projected to grow to USD 3.38 billion in 2026, with a CAGR of 7.33%, reaching USD 5.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.17 billion
Estimated Year [2026] USD 3.38 billion
Forecast Year [2032] USD 5.21 billion
CAGR (%) 7.33%

An authoritative and concise orientation to current gastroscopy device dynamics that primes strategic decision-making across clinical and commercial stakeholders

Gastroscopy remains a cornerstone of gastrointestinal diagnostics and interventions, and the device ecosystem that supports it is undergoing rapid evolution. End users across ambulatory surgical centers, clinics, and hospitals continue to demand higher image fidelity, enhanced ergonomics, and workflows that reduce procedure time and infection risk. At the same time, manufacturers face rising expectations for integrated digital capabilities and post-sale support that extend the lifetime value of capital equipment.

This executive summary synthesizes contemporary technology trends, regulatory pressures, supply chain dynamics, and segmentation behavior that together shape procurement decisions and clinical adoption. It seeks to equip executives, clinical leaders, and supply chain managers with a clear, actionable understanding of where the gastroscope landscape is moving and why. By clarifying key drivers and implications, the following sections provide a strategic foundation for investment prioritization, product development roadmaps, and commercial planning.

A clear synthesis of technological advances, evolving procurement priorities, regulatory emphasis on infection prevention, and digital integration shaping gastroscope adoption

The gastroscope landscape is experiencing a confluence of technological and operational shifts that are transforming clinical pathways and commercial models. High-definition digital imaging and the proliferation of video-based flexible endoscopes have raised diagnostic expectations, while advances in single-use components and sterilization science are reshaping infection control protocols. Concurrently, artificial intelligence tools for lesion detection and image enhancement are moving from pilot studies to routine clinical support, altering both procedural efficiency and clinician training requirements.

In parallel, changing procurement priorities emphasize lifecycle cost, consumables management, and bundled service agreements rather than upfront capital price alone. This shift encourages manufacturers to offer comprehensive service ecosystems that include professional education, remote diagnostics, and data analytics. Moreover, regulatory scrutiny on cross-contamination and environmental impact is prompting renewed attention to reusable device reprocessing pathways and the lifecycle implications of single-use alternatives. Taken together, these transformative shifts create new competitive spaces for companies that can integrate imaging excellence, digital services, and robust clinical evidence into compelling value propositions.

A nuanced analysis of how 2025 tariff recalibrations alter procurement economics, supplier strategies, and regional manufacturing decisions for gastroscope supply chains

Recent tariff adjustments have created a material reframing of global supply chain economics for advanced medical devices and associated consumables. Import tariffs increase landed costs for manufacturers and distributors that rely on cross-border component flows, prompting many organizations to reassess sourcing footprints and supplier diversification. As a result, procurement teams in hospitals and ambulatory settings are placing renewed emphasis on supplier resilience, dual sourcing, and localized inventory buffers to mitigate delivery risk and maintain continuity of care.

Moreover, tariffs encourage strategic shifts in manufacturing investment decisions. Some producers evaluate nearshoring or regional assembly to reduce exposure to trade friction, while others pursue long-term supplier contracts with price stabilization mechanisms. In turn, these adaptations affect channel strategy, with distributors and direct-sales organizations renegotiating commercial terms to preserve margins and service levels. Clinicians and purchasing stakeholders should therefore expect ongoing adjustments in product available configurations, lead times, and pricing conversations as companies balance cost absorption with competitive positioning.

Segment-driven insights that articulate product, end-user, application, and distribution dynamics to inform targeted commercial and clinical strategies

Segmentation analysis reveals differentiated value levers across product types, end-user profiles, clinical applications, and distribution channels. Within product segmentation, flexible and rigid gastroscopes address distinct clinical needs: flexible devices provide access and maneuverability essential for diagnostic and therapeutic workflows, whereas rigid instruments are adopted in specific procedural contexts with different sterilization and reprocessing profiles. The flexible category itself divides into fiberoptic and video technologies, with video systems offering superior imaging, digital integration, and easier incorporation of image analysis tools. Conversely, rigid devices may appear as reusable platforms optimized for durability and cost per procedure, or as single-use disposables that reduce cross-contamination risk and simplify logistics.

End-user segmentation highlights divergent purchasing criteria among ambulatory surgical centers, clinics, and hospitals. Ambulatory surgical centers often prioritize throughput, lower per-procedure costs, and streamlined sterilization, which can favor single-use approaches or compact, service-light systems. Clinics may emphasize diagnostic performance and capital efficiency, seeking versatile platforms that support a range of applications in limited space. Hospitals typically demand enterprise-grade interoperability, service contracts, and solutions that integrate with broader imaging and electronic health record systems.

Application segmentation further clarifies clinical requirements, where combined procedures require modular instruments and flexible platforms that support diagnostic inspection followed by therapeutic intervention. Diagnostic-focused workflows emphasize image clarity, reproducibility, and documentation features, while therapeutic use demands robust working channels, instrument compatibility, and device durability. Distribution channel segmentation rounds out the picture by differentiating direct sales, distributors, and online channel strategies. Direct sales often deliver deep clinical engagement and integrated service offerings, distributors provide regional reach and inventory management, and online channels facilitate rapid procurement of consumables and single-use products. Each distribution pathway influences customer experience, lead times, and the degree of clinical support available post-sale.

An evidence-based regional comparison of clinical adoption drivers, reimbursement patterns, and manufacturing dynamics across key global markets

Regional variations in clinical practice, reimbursement frameworks, and manufacturing ecosystems meaningfully influence adoption patterns and strategic priorities. In the Americas, mature clinical infrastructures and concentrated purchasing networks create opportunities for premium imaging platforms and integrated service agreements, while also motivating investment in localized manufacturing or assembly to reduce tariff exposure and speed time-to-market. As a result, stakeholder dialogues in this region often center on total cost of ownership, interoperability with hospital systems, and the evidence base needed to support adoption.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory complexity and wide variance in healthcare funding shape procurement behavior. In parts of this region, stringent reprocessing standards and centralized purchasing mechanisms encourage durable, reusable systems with comprehensive service offerings. Elsewhere, constrained budgets and the need for rapid deployment drive interest in cost-effective single-use alternatives and online procurement channels. These contrasting incentives require manufacturers to adopt flexible commercial models and region-specific evidence generation strategies.

Asia-Pacific is characterized by rapid capacity expansion, growing procedural volumes, and a mix of domestic manufacturing capabilities alongside multinational investment. Strong demand in this region accelerates adoption of digital imaging and telemedicine-enabled workflows, while regional manufacturing hubs create competitive opportunities for cost-efficient production. Consequently, companies operating in Asia-Pacific must balance innovation with affordability and prioritize partnerships that enhance distribution reach and regulatory navigation.

An incisive appraisal of competitive tactics showing how product innovation, services, and channel strategies are redefining vendor positioning in the gastroscope market

Leading companies in the gastroscope ecosystem are differentiating through innovation in imaging, disposables strategy, and service delivery. Many established manufacturers prioritize high-resolution video systems and modular architectures that facilitate clinical upgrades without full platform replacement. At the same time, a growing set of contenders emphasizes single-use gastroscopes and hybrid service models to address infection control concerns and reduce reprocessing burdens for facilities with constrained sterile processing capacity.

Strategic activity often centers on deepening clinical partnerships, investing in post-market clinical studies, and bundling digital services such as remote diagnostics, predictive maintenance, and outcome tracking. In addition, several players pursue vertical integration across consumables and capital equipment to secure recurring revenue streams and tighten customer relationships. Distribution strategies also vary, with some companies strengthening direct sales forces to support complex institutional procurements, while others expand distributor networks or online platforms to accelerate consumable turnover and reach decentralized provider segments.

Actionable strategic recommendations for manufacturers, providers, and channel partners to convert structural change into durable competitive advantage

Industry leaders can convert market complexity into competitive advantage by aligning product roadmaps with clinical workflows and procurement realities. Manufacturers should prioritize interoperability and modularity to protect customer investments while enabling iterative upgrades that incorporate enhanced imaging and AI capabilities. Simultaneously, investing in robust clinical evidence and real-world outcome tracking will accelerate adoption by demonstrating tangible improvements in diagnostic accuracy and procedural efficiency.

From a supply perspective, diversifying sourcing and evaluating regional manufacturing partnerships will reduce exposure to trade disruptions and tariff volatility. Companies should also design flexible commercial models that accommodate direct hospital procurement, distributor relationships, and online consumable channels to match end-user preferences. For clinical and operational leaders, adopting a lifecycle lens that examines total cost, reprocessing complexity, and clinical throughput will yield better purchasing decisions. Finally, cross-sector collaboration-between device makers, health systems, and payers-can create bundled service offerings that align incentives around improved patient outcomes and predictable cost structures.

A rigorous mixed-methods research framework combining primary stakeholder interviews, regulatory and clinical evidence review, and supply chain analysis to underpin the findings

This research follows a mixed-methods approach that integrates primary stakeholder engagement with secondary evidence triangulation to ensure robust, reproducible insights. Primary inputs include structured interviews with clinical leaders, procurement specialists, device engineers, and distribution executives, supplemented by advisory panels that validate emerging themes and operational priorities. These engagements provide real-world context for clinical workflows, decision criteria, and the practical constraints that shape purchasing cycles.

Secondary analysis draws on regulatory filings, clinical trial registries, patent landscapes, and peer-reviewed clinical literature to map technological maturity and safety evidence. Supply chain mapping and trade flow analysis illuminate sourcing concentrations and vulnerability points, while usability and lifecycle assessments inform discussions about reprocessing and single-use trade-offs. All findings undergo cross-validation through iterative analyst review and expert feedback to reduce bias and improve applicability for strategic planning.

A concise synthesis of strategic imperatives and forward-looking priorities that crystalize the path to safer, more efficient gastroscopy solutions

In summary, the gastroscope landscape is simultaneously conserved in its clinical purpose and dynamic in its commercial and technological expression. Diagnostic clarity, infection-control imperatives, and evolving procurement priorities are converging to reshape product design, distribution, and service models. Strategic responses now revolve around integrating advanced imaging and data capabilities, offering flexible commercial terms, and reinforcing supply chain resilience in the face of tariff and trade uncertainty.

Looking ahead, organizations that align product innovation with demonstrable clinical value and that adopt adaptable manufacturing and go-to-market strategies will be best positioned to capture growth opportunities. Collaboration across clinical, regulatory, and commercial stakeholders will accelerate adoption of safer, more efficient gastroscopy solutions that meet the twin demands of performance and sustainability. The analysis provided here offers a foundation for strategic choices that prioritize patient outcomes while managing operational and economic risk.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastroscopes Market, by Product

  • 8.1. Flexible
    • 8.1.1. Fiberoptic
    • 8.1.2. Video
  • 8.2. Rigid
    • 8.2.1. Reusable
    • 8.2.2. Single Use

9. Gastroscopes Market, by Distribution Channel

  • 9.1. Offline
  • 9.2. Online

10. Gastroscopes Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Gastroscopes Market, by Application

  • 11.1. Combined
  • 11.2. Diagnostic
  • 11.3. Therapeutic

12. Gastroscopes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gastroscopes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gastroscopes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Gastroscopes Market

16. China Gastroscopes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ambu A/S
  • 17.6. Ankon Medical Technologies Co., Ltd.
  • 17.7. Aohua Endoscopy Co., Ltd.
  • 17.8. B. Braun Melsungen AG
  • 17.9. Becton, Dickinson and Company
  • 17.10. Boston Scientific Corporation
  • 17.11. CONMED Corporation
  • 17.12. Cook Medical LLC
  • 17.13. Ethicon
  • 17.14. Fujifilm Holdings Corporation
  • 17.15. KARL STORZ SE & Co. KG
  • 17.16. Medtronic plc
  • 17.17. Mindray Bio-Medical Electronics Co., Ltd.
  • 17.18. Olympus Corporation
  • 17.19. PENTAX Medical
  • 17.20. Richard Wolf GmbH
  • 17.21. Smith & Nephew plc
  • 17.22. SonoScape Medical Corp.
  • 17.23. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROSCOPES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROSCOPES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROSCOPES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROSCOPES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROSCOPES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROSCOPES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROSCOPES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROSCOPES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROSCOPES MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROSCOPES MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROSCOPES MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROSCOPES MARKET SIZE, BY FIBEROPTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROSCOPES MARKET SIZE, BY FIBEROPTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROSCOPES MARKET SIZE, BY FIBEROPTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROSCOPES MARKET SIZE, BY VIDEO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROSCOPES MARKET SIZE, BY VIDEO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROSCOPES MARKET SIZE, BY VIDEO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROSCOPES MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROSCOPES MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROSCOPES MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROSCOPES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROSCOPES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROSCOPES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROSCOPES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROSCOPES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROSCOPES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROSCOPES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROSCOPES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROSCOPES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROSCOPES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROSCOPES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROSCOPES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROSCOPES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROSCOPES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROSCOPES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROSCOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROSCOPES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROSCOPES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROSCOPES MARKET SIZE, BY COMBINED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROSCOPES MARKET SIZE, BY COMBINED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROSCOPES MARKET SIZE, BY COMBINED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROSCOPES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROSCOPES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROSCOPES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROSCOPES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROSCOPES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROSCOPES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS GASTROSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. GCC GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GCC GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 117. GCC GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 119. GCC GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. GCC GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. GCC GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. G7 GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. G7 GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 138. G7 GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 139. G7 GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 140. G7 GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. G7 GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. G7 GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NATO GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. NATO GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. NATO GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 146. NATO GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 147. NATO GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. NATO GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. NATO GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL GASTROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA GASTROSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA GASTROSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA GASTROSCOPES MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA GASTROSCOPES MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA GASTROSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA GASTROSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA GASTROSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)